O que a Evolução pode nos ensinar sobre Raça e Racismo? Entrevista com o Joseph L Graves Jr.

O Dr. Joseph L. Graves Jr., renomado biólogo evolutivo e geneticista norte-americano, da North Carolina A&T State University, concedeu uma entrevista à Revista de Medicina, através dos grupos de pesquisa Race.ID (Grupo de Pesquisa em Saúde da População Negra) e BrEHS (Brazilian Evolution and Health Study Group). Na entrevista, o professor conta sobre sua trajetória, os desafios enfrentados na carreira, o que significa ser um cientista negro nos EUA, as complicadas relações entre a medicina e a ideia de raça e o que a medicina evolutiva tem a ver com tudo isso.Dr. Joseph L. Graves Jr., a renowned American evolutionary biologist and geneticist from North Carolina A&T State University, granted an interview to Revista de Medicina through the research groups Race.ID (Research Group on Black Population Health) and BrEHS (Brazilian Evolution and Health Study Group). In the interview, the professor talks about his journey, the challenges he has faced in his career, what it means to be a Black scientist in the USA, the complex relationship between medicine and the concept of race, and how evolutionary medicine is connected to all of this

Drug use among medical students in São Paulo, Brazil: a cross-sectional study during the coronavirus disease 2019 pandemic

ABSTRACT BACKGROUND: Medical students demonstrate higher rates of substance use than other university students and the general population. The challenges imposed by the coronavirus disease 2019 (COVID-19) pandemic raised significant concerns about mental health and substance use. OBJECTIVES: Assess the current prevalence of substance use among medical students at the University of São Paulo and evaluate the impact of the COVID-19 pandemic on drug consumption. DESIGN AND SETTING: A cross-sectional study was conducted on 275 medical students from the University of São Paulo Medical School (São Paulo, Brazil) in August 2020. METHODS: Substance use (lifetime, previous 12 months, and frequency of use before and during the COVID-19 pandemic) and socioeconomic data were assessed using an online self-administered questionnaire. Symptoms of depression were assessed using the Patient Health Questionnaire-9. RESULTS: Alcohol was the most consumed substance in their lifetime (95.6%), followed by illicit drugs (61.1%), marijuana (60%), and tobacco (57.5%). The most commonly consumed substances in the previous year were alcohol (82.9%), illicit drugs (44.7%), marijuana (42.5%), and tobacco (36%). Students in the first two academic years consumed fewer substances than those from higher years. There was a decreasing trend in the prevalence of most substances used after the COVID-19 pandemic among sporadic users. However, frequent users maintained their drug use patterns. CONCLUSION: The prevalence of substance use was high in this population and increased from the basic to the clinical cycle. The COVID-19 pandemic may have affected the frequency of drug use and prevalence estimates